Laminar distribution of β-amyloid (Aβ) peptide deposits in the frontal lobe in familial and sporadic Alzheimer's disease

被引:12
|
作者
Armstrong, Richard A. [1 ]
机构
[1] Aston Univ, Vis Sci, Birmingham B4 7ET, W Midlands, England
关键词
laminar distribution; beta-amyloid (A beta) peptide deposits; gene mutation; APOLIPOPROTEIN-E; PRECURSOR PROTEIN; INTELLECTUAL STATUS; SENILE DEMENTIA; PLAQUES; BRAIN; CORTEX; PATHOGENESIS; DIAGNOSIS; PATHOLOGY;
D O I
10.5114/fn.2015.49970
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
To determine whether genetic factors influence frontal lobe degeneration in Alzheimer's disease (AD), the laminar distributions of diffuse, primitive, and classic beta-amyloid (A beta) peptide deposits were compared in early-onset familial AD (ED-FAD) linked to mutations of the amyloid precursor protein (APP) or presenilin 1 (PSEN1) gene, late-onset familial AD (LO-FAD), and sporadic AD (SAD). The influence of apolipoprotein E (Apo E) genotype on laminar distribution was also studied. In the majority of FAD and SAD cases, maximum density of the diffuse and primitive A beta deposits occurred in the upper cortical layers, whereas the distribution of the classic A beta deposits was more variable, either occurring in the lower layers, or a double-peaked (bimodal) distribution was present, density peaks occurring in upper and lower layers. The cortical layer at which maximum density of A beta deposits occurred and maximum density were similar in EO-FAD, LO-FAD and SAD. In addition, there were no significant differences in distributions in cases expressing Apo E epsilon 4 alleles compared with cases expressing the epsilon 2 or epsilon 3 alleles. These results suggest that gene expression had relatively little effect on the laminar distribution of A beta deposits in the frontal lobe of the AD cases studied. Hence, the pattern of frontal lobe degeneration in AD is similar regardless of whether it is associated with APP and PSEN1, mutation, allelic variation in Apo E, or with SAD.
引用
收藏
页码:15 / 23
页数:9
相关论文
共 50 条
  • [31] Metabolism of amyloid β peptide and Alzheimer's disease
    Saido, Takaomi C.
    [J]. NEUROSCIENCE RESEARCH, 2007, 58 : S2 - S2
  • [32] Alzheimer's Disease and the Amyloid-β Peptide
    Murphy, M. Paul
    LeVine, Harry, III
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2010, 19 (01) : 311 - 323
  • [33] The amyloid peptide precursor in Alzheimer's disease
    Octave, JN
    [J]. ACTA NEUROLOGICA BELGICA, 1995, 95 (04): : 197 - 209
  • [34] Elevation of β-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells
    Wiltfang, J
    Esselmann, H
    Cupers, P
    Neumann, M
    Kretzschmar, H
    Beyermann, M
    Schleuder, D
    Jahn, H
    Rüther, E
    Kornhuber, J
    Annaert, W
    De Strooper, B
    Saftig, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (46) : 42645 - 42657
  • [35] Distinct cerebrospinal fluid amyloid β peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease
    Portelius, Erik
    Andreasson, Ulf
    Ringman, John M.
    Buerger, Katharina
    Daborg, Jonny
    Buchhave, Peder
    Hansson, Oskar
    Harmsen, Andreas
    Gustavsson, Mikael K.
    Hanse, Eric
    Galasko, Douglas
    Hampel, Harald
    Blennow, Kaj
    Zetterberg, Henrik
    [J]. MOLECULAR NEURODEGENERATION, 2010, 5
  • [36] Frontal lobe function in Alzheimer's disease is predicted by frontal neurofibrillary pathology
    Johnson, JK
    Head, E
    Oshita, MH
    Nielson, KA
    Cotman, CW
    [J]. JOURNAL OF COGNITIVE NEUROSCIENCE, 1998, 10 : 64 - 64
  • [37] Aluminum and Amyloid-β in Familial Alzheimer's Disease
    Mold, Matthew
    Linhart, Caroline
    Gomez-Ramirez, Johana
    Villegas-Lanau, Andres
    Exley, Christopher
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2020, 73 (04) : 1627 - 1635
  • [38] Frontal lobe tasks do not reflect frontal lobe function in patients with probable Alzheimer's disease
    Kessler, J
    Mielke, R
    Grond, M
    Herholz, K
    Heiss, WD
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2000, 104 (1-4) : 1 - 15
  • [39] Temporal and frontal lobe atrophy characterises Alzheimer's disease
    Double, KL
    Halliday, GM
    Kril, JJ
    [J]. BRAIN PATHOLOGY, 1997, 7 (04) : 1201 - 1201
  • [40] Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction
    Senanarong, V
    Cummings, JL
    Fairbanks, L
    Mega, M
    Masterman, DM
    O'Connor, SM
    Strickland, TL
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 17 (1-2) : 14 - 20